FDA Issues Caution to Pet Owners with the Use of an Unapproved Pet Shampoo
Product May 13, 2011
The FDA's Center for Veterinary Medicine is alerting pet owners to use caution
with the use of an unapproved animal drug product, Douxo Seborrhea Shampoo
(0.1% pytosphingosine),
distributed by Sogeval Laboratories, Inc. of Coppell, Texas after recently
receiving a report of the death of a woman associated with the use of the
product on her dog.
The March adverse event report describes a woman with severe, preexisting asthma
who had a sudden, severe asthma attack and died while bathing a dog using the
product, Duxo Seborrhea Shampoo.
A few days later, another asthmatic family member bathed the dog using the same
product and experienced a mild asthma attack but
recovered.
FDA is advising consumers with asthma or other respiratory conditions to
consider consulting with their physicians prior to use of this product.
FDA is currently investigating this serious issue and will provide
addition information as appropriate.
To report an adverse event involving the use of animal drug product, please go
to:
https://www.fda.gov/AnimalVeterinary/SafetyHealth/ReportaProblem/ucm055305.htm
Owners Caution (pet shampoo)
Hybrid Mode
